NCT04089891: A trial that was reported late by Masonic Cancer Center, University of Minnesota
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
Full entry on ClinicalTrials.gov | NCT04089891 |
---|---|
Title | A Phase I/II Trial in Patients With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System |
Results Status | no-longer-act |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Oct. 31, 2019 |
Completion date | Oct. 31, 2024 |
Required reporting date | Oct. 31, 2025, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Aug. 3, 2020 |
Days late | None |